Chemical Market ShareAnalysis C-Reactive Protein (CRP) Test Market Analysis, Man | Page 2

The C–Reactive protein test market is segmented on the basis of assay type (immunoturbidimetric assay, ELISA,
chemiluminescence immunoassay), detection range (hs – CRP, conventional CRP, cCRP), disease area (cardiovascular
diseases, cancer, rheumatoid, arthritis, inflammatory bowel diseases, endometriosis, lupus), end user (clinics,
hospitals, laboratories, assisted living healthcare facilities, home) and region (North America, Europe, Asia Pacific, Latin
America, Middle East and Africa).
Mentioning about the assay type segmentation, in which immunoturbidimetric assay is the fastest growing segment,
because of the players who are highly investing in its R&D sector. In addition to this, immunoturbidimetric tests are
surging and are accepted for protein assays.
Get a Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/c-reactive-protein-crp-test-market-study/request-sample
Considering the end user insights, clinics have been accounted for the largest revenue share and is anticipated to
maintain the same in the forthcoming years. The reason for its rise is the healthcare infrastructure, which acts as a
support to this segment.
North America having the largest revenue share dominates the C–Reactive protein test market. Prominent players,
technological advancements, and well-structured infrastructures are the factors, accountable for the dominance of
this segment. Followed by this region, Asia Pacific is predicted to arise as the fastest growing segment.
Some of the prominent key players of the C–Reactive protein test market are Thermo Fisher Scientific, Inc., HORIBA
Ltd., Randox Laboratories Ltd., Abbott, Siemens Healthineers, F Hoffmann-La Roche Ltd., Quest Diagnostics, Getein
Biotech, Inc., Ortho Clinical Diagnostics, Orion Diagnostica Oy, Laboratory Corporation of America Holdings, BODITECH
MED, INC., Danaher; Merck & Co., Inc., and Abaxis, Inc. All the leading companies are including mergers and
acquisitions, partnerships and joint ventures to enhance the growth of the market efficiently.
Market Segment:
Leading players of C-Reactive Protein Test (CRP) including:
• Beckman Coulter
• Roche
• Siemens Healthcare
• Ortho Clinical Diagnostics
• Boditech